IRIS
BALDARI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.137
EU - Europa 10.016
AS - Asia 2.342
Continente sconosciuto - Info sul continente non disponibili 24
SA - Sud America 13
OC - Oceania 10
AF - Africa 6
Totale 22.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.119
IE - Irlanda 3.068
SE - Svezia 2.879
IT - Italia 1.819
CN - Cina 1.690
DE - Germania 542
UA - Ucraina 483
FI - Finlandia 372
IN - India 361
GB - Regno Unito 339
VN - Vietnam 236
FR - Francia 188
PL - Polonia 113
BE - Belgio 94
RU - Federazione Russa 37
AT - Austria 31
IR - Iran 26
EU - Europa 19
CA - Canada 16
NL - Olanda 16
CL - Cile 11
CH - Svizzera 10
AU - Australia 9
RO - Romania 9
TR - Turchia 8
ES - Italia 6
A1 - Anonimo 3
HK - Hong Kong 3
IL - Israele 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ID - Indonesia 2
IQ - Iraq 2
JP - Giappone 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
Totale 22.548
Salva come PNG Salva come JPEG
Città #
Dublin 3.066
Chandler 2.474
Nyköping 1.666
Jacksonville 1.173
Beijing 723
Ashburn 607
Princeton 508
Medford 474
Dearborn 406
Cambridge 365
Des Moines 351
Ann Arbor 337
Messina 237
Dong Ket 236
Hyderabad 212
New York 197
Boardman 195
Bremen 164
Jinan 149
Lancaster 145
Wilmington 138
Shenyang 121
Pune 117
Warsaw 107
Woodbridge 99
Rome 96
Milan 95
San Mateo 91
Brussels 90
Nanjing 74
Catania 59
Zhengzhou 59
Hebei 52
Houston 52
Tianjin 51
Ningbo 50
Nanchang 49
Seattle 42
Naples 41
Haikou 40
Hangzhou 40
Turin 38
Palermo 37
Taizhou 36
Guangzhou 32
Genoa 31
Fuzhou 30
Norwalk 30
Vienna 30
Washington 30
Augusta 28
Changsha 26
Trieste 26
Los Angeles 24
Lanzhou 23
Jiaxing 20
Falls Church 19
Bari 18
Monmouth Junction 18
Ardabil 17
Leawood 17
Redwood City 17
Taiyuan 16
Clearwater 15
Florence 15
Helsinki 15
Strasbourg 12
Brescia 11
Auburn Hills 10
Bergamo 10
Mumbai 10
Parma 10
Padova 9
Verona 9
Comiso 8
Prato 8
Eboli 7
Hefei 7
Napoli 7
Saint Petersburg 7
Vittoria 7
Cosenza 6
Kunming 6
Novokuznetsk 6
Pedara 6
Riva 6
Syracuse 6
Tappahannock 6
Venice 6
Cagliari 5
Casalnuovo Di Napoli 5
Hanover 5
Istanbul 5
Kemerovo 5
Lappeenranta 5
Lucca 5
Pescara 5
Reggio Calabria 5
Saint Louis 5
Santa Domenica 5
Totale 16.091
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 958
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 174
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 113
Ruolo della scintigrafia con HIG 99mTc (immunoglobuline policlonali marcate) nella colite ulcerosa e nel morbo di Crohn. Risultati preliminari 102
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 97
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 96
The SAMDOCET study: 153Sm-EDTMP and Docetaxel versus Docetaxel in Taxane-naïve patients with metastatic castration-refractory prostate cancer. 96
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 95
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 94
Combined diagnosis in breast carcinoma: preoperative role of mammoscintigraphy with Tc99m-sestamibi. Our Experience 93
111In-Pentetreotide in neuroendocrine tumours. Comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 93
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 88
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 87
PRRT Retreatments: Renal Function Evaluation 86
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 85
SPECT and MRI in Complex Partial Epilepsy. 85
La Chirurgia Radioimmunoguidata (R.I.G.S.) nel carcinoma del colon-retto. Risultati preliminari [Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results] 83
Aggressive pituitary adenomas: the dark side of the moon 83
11C-Choline PET/CT based helical tomotherapy as innovative treatment approach for bone metastases in prostate cancer patients 83
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 81
Modern applications of SPECT in cerebrvascular diseases 81
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 79
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 79
Absorbed fractions for electrons in ellipsoidal volumes 77
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 77
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 77
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 76
Coronary-subclavian steal phenomenon late after coronary artery bypass grafting: an underappreciated cause of myocardial ischemia? 75
Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature 75
Brunner's adenoma, esophageal reflux and gastric ulcer. A case report 74
Resolution of anorexia and resultant weight gain in non organic failure to thrive after domperidone therapy 73
Association of parathyroid carcinoma and thyroid disorders: A clinical review 73
Evaluation of absorbed fractions for beta-gamma radionuclides in ellipsoidal volumes of soft tissue through Geant4 72
99mTc MIBI SPET in revealing underlying neoplasms in brain hemorrhages 72
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 72
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma 71
Differentiated thyroid carcinoma in lingual thyroid 71
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 71
Internal Dosimetry of Ellipsoidal Targets: models and applications 70
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/TC 69
11c-choline pet/ct based helical tomotherapy as treatment approach for bone metastases in recurrent prostate cancer patients 69
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 69
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 68
Recombinant erythropoietin and hypertension 68
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals 68
Studio della perfusione cerebrale nell'idrocefalo in eta' pediatrica 66
The 14CO2 urea breath test for Helicobacter pylori infection 66
Increased 177Lu-DOTATATE Uptake in Paget Disease 66
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 66
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 66
Role of MIBI-99mTc scan in detecting local and distant metastases of differentiated thyroid cancer immediately after total thyroidectomy 65
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 65
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 65
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 65
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 65
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 65
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 64
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 64
Iodine-131 treatment of hyperthyroidism: our experience 64
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 64
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 64
Usefulness of PET-CT scan in recurrent thyroid cancer 64
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 64
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 64
The role of 99mTc-Sestamibi SPET in the preoperative management and differential diagnosis of cerebral lesions 63
Conservative treatment in primary neonatal megaureter 63
Scintigraphic evaluation of colonic motility in patients with anorectal malformations 63
99mTc-MIBI SPECT imaging of acute and subacute non-neoplastic brain haematomas 63
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 63
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 63
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 63
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 63
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 63
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 62
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 62
186Re-HEDP in the treatment of painful bone metastases from cancers other than prostate and breast 62
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 62
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 62
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 62
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 62
BONE-SCAN IN PATIENT WITH HORSESHOE-KIDNEY MIMICKING SKELETAL LUMBAR METASTASIS 61
Erratum: Mid and long-term effects on pulmonary perfusion, anatomy and diaphragamatic motility in survivors of congenital diaphragmatic hernia 61
90Y-dotatoc and/or 111In-pentetreotide in the treatment of somatostatin receptors-expressing tumors (SSTR): personal experience 61
Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer 61
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 61
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 61
THE TREATMENT OF LARGE SUPRATENTORIAL ARACHNOID CYSTS IN INFANTS WITH CYST-PERITONEAL SHUNTING AND HAKIM PROGRAMMABLE VALVE 60
Hepatobiliary imaging in a patient with liver abscess: interesting diagnostic findings 60
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 60
Reversible cerebral perfusion alterations in children with transient mutism after posterior fossa surgery 60
Trattamento dell'ipertiroidismo con attività di radioiodio calcolata per singolo paziente (dosimetria personalizzata). 60
Megauretere primitivo. Indagini diagnostiche, protocolli diagnostici 60
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 60
153Sm-EDTMP in the treatment of painful bone metastases from prostate and breast cancer. Personal experience. 59
90Y-DOTATOC and/or 111In-Pentetreotide in the Treatment of Somatostatin Receptors-Expressing Tumors: Personal Experience 59
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 59
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 59
Absorbed fractions in ellipsoidal volumes for ß- radionuclides employed in internal radiotherapy 58
L'angiodisplasia del tenue, una causa rara di emorragia digestiva. 58
Absorbed fractions for photons in ellipsoidal volumes 58
Totale 8.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201987 0 0 0 0 0 0 0 0 0 0 58 29
2019/20202.648 247 88 26 102 23 404 338 297 74 543 416 90
2020/20212.740 254 28 620 148 242 240 43 124 119 268 283 371
2021/20223.465 47 468 49 110 154 34 199 177 39 521 483 1.184
2022/20239.159 747 987 441 737 699 918 131 503 3.615 61 226 94
2023/20242.927 196 332 205 292 247 655 144 232 104 419 101 0
Totale 23.177